Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells

November 26, 2015

To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.

Previous Article
Mind-body medicine can ward off more heart attacks compared to conventional prevention programs
Mind-body medicine can ward off more heart attacks compared to conventional prevention programs

Mind-body medicine (MBM) is a holistic approach that has the potential to ward off more heart attacks than ...

Next Article
Study points to new avenue for developing potential strategies to thwart HIV virus
Study points to new avenue for developing potential strategies to thwart HIV virus

Nearly 37 million people worldwide are living with HIV. When the virus destroys so many immune cells that t...